NCT00822107View on ClinicalTrials.gov

A Translational Approach to Gitelman Syndrome

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2013

Study Completion Date

September 30, 2013

Conditions
Gitelman Syndrome
Interventions
DRUG

Hydrochlorothiazide

50 mg one time

Trial Locations (1)

97239

Oregon Health & Science University, Portland

Sponsors
All Listed Sponsors
collaborator

Oregon Clinical and Translational Research Institute

OTHER

lead

Oregon Health and Science University

OTHER